title: In vitro antimicrobial activity of rifaximin against enteropathogens causing traveler's diarrhea.
abstract: The in vitro activity of rifaximin against 84 diarrheagenic Escherichia coli and 11 Shigella sonnei causing traveler's diarrhea was evaluated. The MIC of rifaximin ranged between <0.007 and 32 mg/L; other agents tested had an MIC of >256 mg/L in most cases. The results showed the potential use of rifaximin to treat these infections.
authors: Hospital Clinic, Centro de Salud Internacional (CRESIB); IDIBAPS, Universitat de Barcelona, 08036-Barcelona, Spain. joruiz@clinic.ub.es
authors: Joaquim
authors: J
authors: Ruiz
authors: Laura
authors: L
authors: Mensa
authors: Cristina
authors: C
authors: O'Callaghan
authors: Maria J
authors: MJ
authors: Pons
authors: Ana
authors: A
authors: González
authors: Jordi
authors: J
authors: Vila
authors: Joaquim
authors: J
authors: Gascón
mesh_terms: D000890:Anti-Infective Agents / Q000494:pharmacology*; D003967:Diarrhea / Q000382:microbiology*; D024881:Drug Resistance, Bacterial; D054307:Enterotoxigenic Escherichia coli / Q000187:drug effects* / Q000302:isolation & purification; D006801:Humans; D008826:Microbial Sensitivity Tests; D012294:Rifamycins / Q000494:pharmacology*; D000078262:Rifaximin; D012764:Shigella sonnei / Q000187:drug effects* / Q000302:isolation & purification; D014195:Travel
chemical_list: D000890:Anti-Infective Agents; D012294:Rifamycins; D000078262:Rifaximin